Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
March 20, 2018
Patent Application Number
14403779
Date Filed
June 7, 2013
Patent Primary Examiner
Patent abstract
The invention provides indazole guanidine compounds that inhibit F1F0-ATPase, and methods of using indazole guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
